Search details
1.
mRNA Vaccine-Elicited Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2)-Specific T Cells Persist at 6 Months and Recognize the Delta Variant.
Clin Infect Dis
; 75(1): e898-e901, 2022 08 24.
Article
in English
| MEDLINE | ID: mdl-34694362
2.
Discordant Antibody and T-Cell Responses to the Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant in Coronavirus Disease 2019 Messenger RNA Vaccine Recipients.
Clin Infect Dis
; 75(9): 1652-1654, 2022 10 29.
Article
in English
| MEDLINE | ID: mdl-35438751
3.
The BNT162b2 mRNA Vaccine Elicits Robust Humoral and Cellular Immune Responses in People Living With Human Immunodeficiency Virus (HIV).
Clin Infect Dis
; 74(7): 1268-1270, 2022 04 09.
Article
in English
| MEDLINE | ID: mdl-34293114
4.
Differentiation of Individuals Previously Infected with and Vaccinated for SARS-CoV-2 in an Inner-City Emergency Department.
J Clin Microbiol
; 60(3): e0239021, 2022 03 16.
Article
in English
| MEDLINE | ID: mdl-35044204
5.
CD4+ T cells from COVID-19 mRNA vaccine recipients recognize a conserved epitope present in diverse coronaviruses.
J Clin Invest
; 132(5)2022 03 01.
Article
in English
| MEDLINE | ID: mdl-35061630
6.
Decay of coronavirus disease 2019 mRNA vaccine-induced immunity in people with HIV.
AIDS
; 36(9): 1315-1317, 2022 07 15.
Article
in English
| MEDLINE | ID: mdl-35833684
7.
SARS-CoV-2 vaccination diversifies the CD4+ spike-reactive T cell repertoire in patients with prior SARS-CoV-2 infection.
EBioMedicine
; 80: 104048, 2022 Jun.
Article
in English
| MEDLINE | ID: mdl-35533495
8.
SARS-CoV-2-specific immune responses in boosted vaccine recipients with breakthrough infections during the Omicron variant surge.
JCI Insight
; 7(10)2022 05 23.
Article
in English
| MEDLINE | ID: mdl-35389888
9.
Adaptive immune responses in vaccinated patients with symptomatic SARS-CoV-2 Alpha infection.
JCI Insight
; 7(5)2022 03 08.
Article
in English
| MEDLINE | ID: mdl-35104245
10.
SARS-CoV-2 mRNA vaccines induce broad CD4+ T cell responses that recognize SARS-CoV-2 variants and HCoV-NL63.
J Clin Invest
; 131(10)2021 05 17.
Article
in English
| MEDLINE | ID: mdl-33822770
11.
CD8 Effector T Cells Function Synergistically With Broadly Neutralizing Antibodies to Enhance Suppression of HIV Infection.
Front Immunol
; 12: 708355, 2021.
Article
in English
| MEDLINE | ID: mdl-34394110
12.
Differentiation of SARS-CoV-2 naturally infected and vaccinated individuals in an inner-city emergency department.
medRxiv
; 2021 Oct 14.
Article
in English
| MEDLINE | ID: mdl-34671778
13.
Functional characterization of CD4+ T cell receptors crossreactive for SARS-CoV-2 and endemic coronaviruses.
J Clin Invest
; 131(10)2021 05 17.
Article
in English
| MEDLINE | ID: mdl-33830946
14.
A Comparison of Different Immune Activation Strategies to Reverse HIV-1 Latency.
Open Forum Infect Dis
; 7(4): ofaa082, 2020 Apr.
Article
in English
| MEDLINE | ID: mdl-32284948
15.
Healthy donor T cell responses to common cold coronaviruses and SARS-CoV-2.
J Clin Invest
; 130(12): 6631-6638, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32966269
16.
A T Cell Receptor Sequencing-Based Assay Identifies Cross-Reactive Recall CD8+ T Cell Clonotypes Against Autologous HIV-1 Epitope Variants.
Front Immunol
; 11: 591, 2020.
Article
in English
| MEDLINE | ID: mdl-32318072
17.
Elite suppressors have low frequencies of intact HIV-1 proviral DNA.
AIDS
; 34(4): 641-643, 2020 03 15.
Article
in English
| MEDLINE | ID: mdl-31895150
18.
Long-term remission despite clonal expansion of replication-competent HIV-1 isolates.
JCI Insight
; 3(18)2018 09 20.
Article
in English
| MEDLINE | ID: mdl-30232278
19.
Cross-reactive microbial peptides can modulate HIV-specific CD8+ T cell responses.
PLoS One
; 13(2): e0192098, 2018.
Article
in English
| MEDLINE | ID: mdl-29466365
20.
Low neutralisation of the omicron BA.2 sublineage in boosted individuals who had breakthrough infections.
Lancet Microbe
; 3(9): e644, 2022 09.
Article
in English
| MEDLINE | ID: mdl-35752198